![Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes]()
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with DiabetesHome, Philip; Derwahl, Karl-Michael; Ziemen, Monika; Wernicke-Panten, Karin; Pierre, Suzanne; Kirchhein, Yvonne; Garg, Satish K. · Diabetes Technology & Therapeutics · 2018